"בית החולים של הדסה בהר הצופים, משרת את אוכלוסיית ירושלים רבתי, ואת הישובים צפונה, ומזרחה לה."

During the past decade, Hadassah University Hospital - Mount Scopus conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 10 clinical trials were completed, i.e. on average, 76.9% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 9 clinical trials were completed. i.e. 180% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hadassah University Hospital - Mount Scopus" #1 sponsor was "PTC Therapeutics" with 5 trials, followed by "Kowa Research Europe" with 4 trials sponsored, "Takeda" with 3 trials sponsored, "Vertex Pharmaceuticals Incorporated" with 3 trials sponsored and "Bayer" with 3 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hadassah University Hospital - Mount Scopus" #1 collaborator was "Cystic Fibrosis Foundation" with 2 trials as a collaborator, "Forest Laboratories" with 2 trials as a collaborator, "Takeda Development Center Americas, Inc." with 2 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator and "ICON plc" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Hadassah University Hospital - Mount Scopus" are "Cystic Fibrosis" (11 trials), "Diabetes Mellitus, Type 2" (2 trials), "Dyslipidemia" (2 trials), "Heart Failure" (2 trials) and "Hypercholesterolemia" (2 trials). Many other conditions were trialed in "Hadassah University Hospital - Mount Scopus" in a lesser frequency.

Most popular intervention types in "Hadassah University Hospital - Mount Scopus" are "Drug" (23 trials), "Behavioral" (1 trials), "Biological" (1 trials), "Device" (1 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Ataluren" (4 trials), "Pitavastatin" (4 trials), "ELX/TEZ/IVA" (3 trials) and "IVA" (3 trials). Other intervention names were less common.

The vast majority of trials in "Hadassah University Hospital - Mount Scopus" are 23 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Hadassah University Hospital - Mount Scopus". 1 are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 19 completed trials in Hadassah University Hospital - Mount Scopus, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Hadassah University Hospital - Mount Scopus, 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 18 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".